Appreciate they can’t state with certainty that it will go ahead because it depends on any SAE that might surface in cohort #3.
I just found it strange that they didn’t mention it.
Ann: RP11 Clinical Trial Progressing To High Dose Cohort, page-8
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.9¢ | $142.4K | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 301768 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 361962 | 6 |
View Market Depth
| Last trade - 13.34pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
0.005 ( 1.01 %) |
||||
| Open | High | Low | Volume | ||
| 10.0¢ | 10.5¢ | 9.9¢ | 510523 | ||
| Last updated 13.17pm 15/05/2024 ? | |||||
| PYC (ASX) Chart |